Vimal Patel Joins Eurofins Bioanalytical Services As Scientific Director For Large Molecule Bioanalysis

ST. CHARLES, Mo., Dec. 16, 2015 /PRNewswire/ -- Eurofins Bioanalytical Services, part of the broad-service Eurofins Pharma Services Group and a leading provider of bioanalytical testing to the biopharmaceutical, today announced that Vimal Patel has joined the company as Scientific Director for large molecule bioanalysis based at the company's St Charles, MO facility.

Logo - http://photos.prnewswire.com/prnh/20151215/296083LOGO

Mr. Patel will serve as a scientific and technical advisor for clients and internal teams for development, validation, and application of assays to ensure compliance with scientific and technical goals and regulatory requirements. He will also drive new technology and services strategy, and lead client development programs with a focus on expanding the large molecule bioanalysis capabilities and customer base.

"Vimal's proven scientific leadership experience is a great addition for Eurofins Bioanalytical Services and our clients," said Dr. Jim Hulse, General Manager of Eurofins Bioanalytical Services. "Vimal brings a unique set of experiences that will enhance understanding of our clients' needs so we can continue to build strong relationships with our clients focusing on performance and transparency."

Vimal has held positions of increasing responsibility within the biopharmaceutical industry. After receiving his BSc in Biology from Cal State Los Angeles, Vimal joined Biosource and then moved to Amgen as a Scientist specializing in assay development, automation, new technologies and the application of Design of Experimentation to improve method transfer and validation. Vimal then joined ICON PLC as the Director of Business Development for bioanalytical sciences before joining Eurofins Bioanalytical Services. Vimal has served in leadership positions in various industry organizations, including the AAPS NBC DOE workshops and as an invited speaker at multiple industry events.

For more information, please contact email

Eurofins - a global leader in bio-analysis

Eurofins Scientific is the world leader in food and pharmaceutical products testing. It is also number one in the world in the field of environmental laboratory services and one of the global market leaders in agroscience, genomics and central laboratory services. With over 15,000 staff in more than 190 laboratories across 37 countries, Eurofins offers a portfolio of over 100,000 reliable analytical methods for evaluating the safety, identity, composition, authenticity, origin and purity of biological substances and products. The Group provides its customers with high-quality services, accurate results on time and expert advice by its highly qualified staff.

Contact:
Craig Draper
636 362 7019

Suggested Articles

Roche is spending up to $1.4 billion to snap up a scarring-focused biotech, nabbing an FDA breakthrough-tagged therapy in the process.

The deal gives Sarepta exclusive licenses to four CNS targets plus an option to pay a further $42.5 million to add another four targets to the deal.

In this week's EuroBiotech Report, AstraZeneca plans 2020 lupus filing, Roche's SMA trial hits endpoint and Kiadis cuts staff in R&D pivot.